Thomas Goldner

Friedrich Ebert Str. 475
Wuppertal, NW 42117, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 9 publications

Discovery of AIC263282, a Hepatitis B Virus Capsid Assembly Modulator Ready for Candidate Profiling.

Discovery of AIC263282, a Hepatitis B Virus Capsid Assembly Modulator Ready for Candidate Profiling.

Journal: Journal of medicinal chemistry

Published: March 19, 2025

Structure-based Design of Novel Hepatitis B Virus Capsid Assembly Modulators.

Structure-based Design of Novel Hepatitis B Virus Capsid Assembly Modulators.

Journal: Bioorganic & medicinal chemistry letters

Published: February 10, 2023

An automated microfluidic platform for the screening and characterization of novel hepatitis B virus capsid assembly modulators.

An automated microfluidic platform for the screening and characterization of novel hepatitis B virus capsid assembly modulators.

Journal: Analytical methods : advancing methods and applications

Published: December 17, 2021

Efficacy of pritelivir and acyclovir in the treatment of herpes simplex virus infections in a mouse model of herpes simplex encephalitis.

Efficacy of pritelivir and acyclovir in the treatment of herpes simplex virus infections in a mouse model of herpes simplex encephalitis.

Journal: Antiviral research

Published: September 05, 2017

Mutual Interplay between the Human Cytomegalovirus Terminase Subunits pUL51, pUL56, and pUL89 Promotes Terminase Complex Formation.

Mutual Interplay between the Human Cytomegalovirus Terminase Subunits pUL51, pUL56, and pUL89 Promotes Terminase Complex Formation.

Journal: Journal of virology

Published: December 09, 2016

No Evidence of Pritelivir Resistance Among Herpes Simplex Virus Type 2 Isolates After 4 Weeks of Daily Therapy.

No Evidence of Pritelivir Resistance Among Herpes Simplex Virus Type 2 Isolates After 4 Weeks of Daily Therapy.

Journal: The Journal of infectious diseases

Published: December 29, 2015

Phenotypic characterization of two naturally occurring human Cytomegalovirus sequence polymorphisms located in a distinct region of ORF UL56 known to be involved in in vitro resistance to letermovir.

Phenotypic characterization of two naturally occurring human Cytomegalovirus sequence polymorphisms located in a distinct region of ORF UL56 known to be involved in in vitro resistance to letermovir.

Journal: Antiviral research

Published: December 09, 2014

Pharmacokinetics-pharmacodynamics of the helicase-primase inhibitor pritelivir following treatment of wild-type or pritelivir-resistant virus infection in a murine herpes simplex virus 1 infection model.

Pharmacokinetics-pharmacodynamics of the helicase-primase inhibitor pritelivir following treatment of wild-type or pritelivir-resistant virus infection in a murine herpes simplex virus 1 infection model.

Journal: Antimicrobial agents and chemotherapy

Published: April 23, 2014

Geno- and phenotypic characterization of human cytomegalovirus mutants selected in vitro after letermovir (AIC246) exposure.

Geno- and phenotypic characterization of human cytomegalovirus mutants selected in vitro after letermovir (AIC246) exposure.

Journal: Antimicrobial agents and chemotherapy

Published: November 06, 2013

Showing 1-9 of 9

Last Updated: 09/26/2026